Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Pain, Postoperative 2Agnosia 2Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Thymoma 1Nephrolithiasis 1Lymphedema 1Lung Neoplasms 1Liver Neoplasms 1Leiomyoma 1Laparoscopic Surgery 1Kidney Neoplasms 1Duodenal Neoplasms 1Cerebrovascular Disorders 1

Interventions

Endoscopic Mucosal Resection 2X-Rays 1Tissue Adhesives 1Tea 1Phantoms, Imaging 1Pancreaticojejunostomy 1Octreotide 1Iopamidol 1Hydromorphone 1Hydrocortisone 1High-Energy Shock Waves 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Duodenal Neoplasms × Bupivacaine × Clear all
NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡